期刊文献+

结核DNA疫苗免疫策略研究进展 被引量:7

下载PDF
导出
摘要 近年来,结核DNA疫苗的研制得到飞速发展,在传统结核DNA疫苗的基础上构建新型DNA疫苗以及基于结核DNA疫苗的PrimeBoost免疫策略的研究成为热点,新的接种途径及接种技术有助于提高DNA疫苗在试验动物的免疫保护作用,同时对结核DNA疫苗的安全性也不可忽视。
出处 《微生物学免疫学进展》 2005年第2期79-82,共4页 Progress In Microbiology and Immunology
  • 相关文献

参考文献30

  • 1www. who. int [EB].
  • 2陈峻崧,王净,等.结核杆菌DNA疫苗研究近况[J].微生物学免疫学进展,2002,30(4):61-64. 被引量:5
  • 3Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science[J].1990, 247(4949 Pt 1) :1465-1468.
  • 4Nabel EG,Plautz G,Nabel GJ.Site-specific gene expression in vivo by direct gene transfer into the arterial wall [J].Science 1990, 249(4974):1285-1288.
  • 5Lowrie DB,Tascon RE,Colston M J,et al.Towards a DNA vaccine against tuberculosis [J].Vaccine 1994,12(16):1537-1540.
  • 6Lowrie DB,Silva CL,Colston MJ,et al.Protection against tuberculosis by a plasmid DNA vaccine[J].Vaccine 1997, 15 (8) :834-838.
  • 7Lozes E,Huygen K,Content J,et al.Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding thecomponents of the secreted antigen 85 complex[J].Vaccine 1997,15(8):830-833.
  • 8Pahor M.Mycobacterium tuberculosis genome sequence completed[J].J Am Gefiatr Soc 1998,46(5):627.
  • 9Kamath AT,Feng CG,Macdonald M,et al.Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis [J].Infect-Immun 1999,67(4):1702-1707.
  • 10Morris S,Kelley C,Howard A,et al.The immunogenicity of single and combination DNA vaccines against tuberculosis[J].Vaccine 2000, 18(20):2155-2163.

二级参考文献30

  • 1KAMATH A T, HANKE T, BRISCOE H,et al. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective efficacy against mycobacterium tuberculosis[J]. Immunology, 1999,96(4) :511-516.
  • 2HUYGEN K, CONTENT J,DENIS O,et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine[ J]. Nature Medicine,1996,2(8) :893-898.
  • 3TASCON R E, STAVROPOULOS E,LUKACS K V,et al.Protection against mycobacterium tubemulosis infection by CD8 + T cells requires the production of gamma interferon[ J]. Infect Immun, 1998,66(2) :830-834.
  • 4BAROUCH D H,SANTRA S, STEENBEKE T D, et al. Augmentation and supression of immune responses to an HIV-1 DNA vaccine by plasimd cytokinc/Ig administration [ J ]. J Immunol, 1998, 161(4) : 1875-1882.
  • 5萨姆布鲁克J 弗里奇EF 曼尼阿蒂斯T 等.分子克隆实验指南 第2版[M].北京:科学出版社,1992.50—54.
  • 6Orme IM. Beyond BCG: The potential for a more effective TB vaccine. Mol Med Today, 1999, 5:487 -492
  • 7Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E ,Fineberg HV. Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. J Am Med Asso, 1994, 271 : 698 -702
  • 8Brooks JV, Frank AA, Keen MA, Bellisle JT, Orme IM. Boosting vaccine for tuberculosis. Infect Immun, 2001,69 : 2714 -2717
  • 9Hess J, Miko D. Catic A, Lehmensiek V, Russell DG. Kaufmann SH. Mycobacterium bovis bacilli Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc Natl Acad Sci USA,1998, 95:5299 -5304
  • 10Pardoll DM. Spinning molecular immunology into successful immunotherapy. Nat rev immunol, 2002, 2 : 227 - 238

共引文献20

同被引文献67

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部